Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
Clinical Non-Inferiority of Pancreatic Enzymes (Norzyme ® - Bergamo) Compared To Creon ® (Solvay Pharmaceutical) in Patients With Exocrine Pancreatic Insufficiency
The recruitment status of this study is unknown because the information has not been verified recently.
Verified November 2009
by L.A.L Clinica Pesquisa e Desenvolvimento Ltda..
Recruitment status was Active, not recruiting
Study NCT01012908 Information provided by L.A.L Clinica Pesquisa e Desenvolvimento Ltda.
First Received on November 11, 2009. Last Updated on October 26, 2010
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
Exocrine Pancreatic Insufficiency
More general conditions related to this trial
Digestive System Diseases
Interventions listed in this trial
Norzyme - Bergamo
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
Sponsors listed in this trial
L.A.L Clinica Pesquisa e Desenvolvimento Ltda.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers